Interventional Cardiologist @UMMC_heart | @HenryFordHealth & @MountSinaiNYC alumni | Researcher #ComplexPCI #MCS #CardiogenicShock | 🇵🇪
Joined May 2011
- Tweets329
- Following548
- Followers1.2K
- Likes1.9K
Alejandro Lemor MD, MS retweeted
Do contemporary sites with the capabilities of MCS escalation have better outcomes than pts included in NCSI (Impella capable hospitals using a CS protocol w/ or w/o escalation capabilities and dedicated CICUs) ?
Data from CERAMICS presented at @SCAI!
It was great to have Dr Karthik Ananth (@HenryFordHealth ) for @UMMCMedicine Grand Rounds and update us all on "Cardiovascular PET Imaging”.
Alejandro Lemor MD, MS retweeted
📖PVAD-supported high-risk #PCI in non-shock patients may be associated with improved clinical out-comes compared with #IABP support 💡Read more ⤵️
➡️jscai.org/article/S2772-9303…
@AlexandraLansky @TayyabShahMD @JWMoses @AlejandroLemor @BillONeillMD
#PercutaneousCoronaryIntervention #PercutaneousVentricularAssistDevice #IntraAorticBalloonPump
Alejandro Lemor MD, MS retweeted
Very important work led by @JasmineMarquard & Danger Investigators w/ improved outcomes observed w/ MV-PCI compared to culprit vessel PCI (hypothesis generating), similar to what @AlejandroLemor showed in #NCSI. Very low rate of CTO PCI (6%), all STEMI, no comatose OHCA
Alejandro Lemor MD, MS retweeted
Department of Medicine Grand Rounds Tuesday, September 30th at noon, Dr. Alejandro Lemor will present "Contemporary Management of Cardiogenic Shock" in R354 and WebEx umc.webex.com/umc/j.php?MTID…
Alejandro Lemor MD, MS retweeted
🚨 New Findings from PROTECT III: focused on pt baseline characteristics & short- intermediate outcomes when treated with #Impella-supported #HRPCI.
➡️doi.org/10.1016/j.jscai.2025…
@FalahBatla @TayyabShahMD @abu_much @djc795 @BjornRedfors @SuzanneJBaron @Babar_Basir @adityadoc1 @AlejandroLemor @agtruesdell @BillONeillMD @_WayneBatchelor
#HighRiskPCI #PCI #CABG
Novel risk score for Impella-HRPCI to calculate in-hospital mortality.
Easy to remember and can be useful to discuss risk of mortality with patients undergoing #HRPCI.
📌 sciencedirect.com/science/ar…
When patients were stratified into 2 cohorts based on HRPCI score (scores 0–4 vs. scores 5–8) 30-day mortality was significantly higher among those with scores 5–8 (5.4 % vs. 17.0 %, HR [95 % CI] = 3.4 [2.12–5.51], p < 0.0001)
@mmamas1973 @MichaelMegalyMD @jbspadoni @PedroMDMSc @AGoldsweig @DrChuckSimonton @KhandelwalMD @KAlaswadMD @behnam_tehrani @UMMC_Heart
Alejandro Lemor MD, MS retweeted
Wonderful work led by @ImranAziz96 @AhmadJabri8 & YingXu on flow characteristics of reperfusion sheaths w large bore MCS. No difference b/t sheath sizes (as it relates to flow), better flow w active flow vs passive. Need detected sheaths in the future.
sciencedirect.com/science/ar…
Alejandro Lemor MD, MS retweeted
Save the date! 🗓️ Join us for the Cardiogenic Shock LATAM Symposium 🫀⚡️in beautiful Cancun! An unmissable event for experts and innovators in the field. Stay tuned for more details! #CShockLATAM @TecSaludMX @GTorreAmione
Alejandro Lemor MD, MS retweeted
📘#SCAIMCSebook Highlight: Chapter 7—Treatment Escalation Guidelines. Early intervention is critical and knowing when to escalate MCS starts with identifying worsening or undertreated #CardiogenicShock. This chapter explores escalation options, key parameters for deteriorating hemodynamics, and the role of a shock team in decision-making. It also features device options for uni- and biventricular support, along with case examples.
🔗 scaipro.scai.org/URL/MCSEboo…
#Cardiology
@Babar_Basir @AlejandroLemor, @kjkunkelmd @AdhirShroff @agtruesdell @duanepinto
Alejandro Lemor MD, MS retweeted
Discover the foundations of #CardiogenicShock and #MCS with SCAI's newest ebook, “Short-Term Mechanical Circulatory Support for Cardiogenic Shock” 📘➡️ scaipro.scai.org/URL/MCSEboo…
📖 Section 1 dives into critical topics, including understanding #CS, the use of right heart catheterization for hemodynamic assessment, pharmacotherapy, treatment escalation, and the importance of specialized shock protocols and teams.
#SCAIMCSebook #HeartTeamApproach #CardiologyEducation #CardioTwitter #CardioX #CardioEd
@BurkhoffDaniel @ICUDocAP @kjkunkelmd @ericalanosborn @cmrosner @ShashankSinhaMD @behnam_tehrani
Alejandro Lemor MD, MS retweeted
More “why-when MCS” for high-risk PCI: “Clinical Outcomes of Patients Experiencing Transient Loss of Pulse Pressure During High-Risk PCI with Impella”👉: 🔗 onlinejcf.com/article/S1071-……
Alejandro Lemor MD, MS retweeted
Have you ever wondered if LOPP during HR-PCI meant anything? Interesting 1/2 of HR-PCI pts supported w/ Impella experienced LOPP. It was not benign! LOPP was associated w/ increased rates of MACCE. More to come in the Protect IV trial. @GreggWStone @duanepinto @JWMoses
Alejandro Lemor MD, MS retweeted
Very important work on RVD in NCSI led by @SarahGorgis @krtkgpt @AlejandroLemor. RVD (defined as RA > 12, PAPI <1) was present in about ~30% of AMI-CS pts. Pts w RVD were sicker, had higher SCAI shock stage, lactate & worse mortality. @JCardFail
sciencedirect.com/science/ar…
Alejandro Lemor MD, MS retweeted
Check out the #SCAISHOCK 2024 preliminary program for a first look at some of the sessions you can attend during the conference this October 17-19 ➡️ scai.confex.com/scai/shock24…
📌Register now to join us in Washington, DC: scai.org/2024-scai-shock/reg…
#CardiogenicShock #Shock
Alejandro Lemor MD, MS retweeted
Case submission is open for SCAI Shock! Best saves, worst complications, interesting hemodynamics we want it all! @SCAI @scaielm @Allison_Dupont @SandeepNathanMD @JasonKatzMD @DrRobRoswell @agtruesdell @PerwaizMeraj
The #SCAISHOCK 2024 Call for Cases is OPEN! ⚡ Submit abstracts for the opportunity to share your research and knowledge to improve clinical practices and treatments of #CardiogenicShock. The deadline to submit cases is August 5.
➡️Learn more and submit: scai.org/2024-scai-shock/cal…
Alejandro Lemor MD, MS retweeted
Our analysis of patients with chronic kidney disease (first report of dialysis pts) who received Impella assisted HRPCI in Protect III @CircIntv #CirculationIntv #MedTwitter #CardioTwitter
💥Lower eGFR had more severely calcified CAD, greater atherectomy usage but no increased risk of procedural complications
💥eGFR <30/dialysis pts had higher 90 day MACE and 1 year mortality (in line with other PCI & CABG studies)
💥no statistically significant differences in outcomes between groups until eGFR<30
ahajournals.org/doi/abs/10.1…
@BillONeillMD @Babar_Basir @AlexandraLansky @SuzanneJBaron @DrCindyGrines @_WayneBatchelor @abu_much
